Meigs James B, Manning Alisa K, Fox Caroline S, Florez Jose C, Liu Chunyu, Cupples L Adrienne, Dupuis Josée
General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
BMC Med Genet. 2007 Sep 19;8 Suppl 1(Suppl 1):S16. doi: 10.1186/1471-2350-8-S1-S16.
Susceptibility to type 2 diabetes may be conferred by genetic variants having modest effects on risk. Genome-wide fixed marker arrays offer a novel approach to detect these variants.
We used the Affymetrix 100K SNP array in 1,087 Framingham Offspring Study family members to examine genetic associations with three diabetes-related quantitative glucose traits (fasting plasma glucose (FPG), hemoglobin A1c, 28-yr time-averaged FPG (tFPG)), three insulin traits (fasting insulin, HOMA-insulin resistance, and 0-120 min insulin sensitivity index); and with risk for diabetes. We used additive generalized estimating equations (GEE) and family-based association test (FBAT) models to test associations of SNP genotypes with sex-age-age2-adjusted residual trait values, and Cox survival models to test incident diabetes.
We found 415 SNPs associated (at p < 0.001) with at least one of the six quantitative traits in GEE, 242 in FBAT (18 overlapped with GEE for 639 non-overlapping SNPs), and 128 associated with incident diabetes (31 overlapped with the 639) giving 736 non-overlapping SNPs. Of these 736 SNPs, 439 were within 60 kb of a known gene. Additionally, 53 SNPs (of which 42 had r2 < 0.80 with each other) had p < 0.01 for incident diabetes AND (all 3 glucose traits OR all 3 insulin traits, OR 2 glucose traits and 2 insulin traits); of these, 36 overlapped with the 736 other SNPs. Of 100K SNPs, one (rs7100927) was in moderate LD (r2 = 0.50) with TCF7L2 (rs7903146), and was associated with risk of diabetes (Cox p-value 0.007, additive hazard ratio for diabetes = 1.56) and with tFPG (GEE p-value 0.03). There were no common (MAF > 1%) 100K SNPs in LD (r2 > 0.05) with ABCC8 A1369S (rs757110), KCNJ11 E23K (rs5219), or SNPs in CAPN10 or HNFa. PPARG P12A (rs1801282) was not significantly associated with diabetes or related traits.
Framingham 100K SNP data is a resource for association tests of known and novel genes with diabetes and related traits posted at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007 webcite. Framingham 100K data replicate the TCF7L2 association with diabetes.
2型糖尿病易感性可能由对风险有适度影响的基因变异所致。全基因组固定标记阵列提供了一种检测这些变异的新方法。
我们在1087名弗雷明汉后代研究家庭成员中使用了Affymetrix 100K SNP阵列,以研究与三种糖尿病相关的定量血糖性状(空腹血糖(FPG)、糖化血红蛋白A1c、28年时间平均FPG(tFPG))、三种胰岛素性状(空腹胰岛素、HOMA胰岛素抵抗和0 - 120分钟胰岛素敏感性指数)以及糖尿病风险的遗传关联。我们使用加性广义估计方程(GEE)和基于家系的关联检验(FBAT)模型来检验SNP基因型与性别 - 年龄 - 年龄²调整后的残差性状值之间的关联,并使用Cox生存模型来检验糖尿病发病情况。
我们发现415个SNP在GEE中与六个定量性状中的至少一个相关(p < 0.001),在FBAT中有242个(18个与GEE重叠,共639个非重叠SNP),128个与糖尿病发病相关(31个与639个重叠),得出736个非重叠SNP。在这736个SNP中,439个位于已知基因距离60 kb范围内。此外,53个SNP(其中42个相互之间r² < 0.80)对于糖尿病发病以及(所有3个血糖性状或所有3个胰岛素性状,或2个血糖性状和2个胰岛素性状)的p < 0.01;其中,36个与其他736个SNP重叠。在100K SNP中,一个(rs7100927)与TCF7L2(rs7903146)处于中度连锁不平衡(r² = 0.50),并与糖尿病风险相关(Cox p值0.007,糖尿病的加性风险比 = 1.56)以及与tFPG相关(GEE p值0.03)。没有常见的(MAF > 1%)100K SNP与ABCC8 A1369S(rs757110)、KCNJ11 E23K(rs5219)处于连锁不平衡(r² > 0.05),也没有与钙蛋白酶10或肝细胞核因子α中的SNP处于连锁不平衡。PPARG P12A(rs1801282)与糖尿病或相关性状无显著关联。
弗雷明汉100K SNP数据是用于已知和新基因与糖尿病及相关性状关联测试的资源,可在http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007网站查询。弗雷明汉100K数据重复了TCF7L2与糖尿病的关联。